1. Home
  2. WW vs PRLD Comparison

WW vs PRLD Comparison

Compare WW & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WW
  • PRLD
  • Stock Information
  • Founded
  • WW 1961
  • PRLD 2016
  • Country
  • WW United States
  • PRLD United States
  • Employees
  • WW N/A
  • PRLD N/A
  • Industry
  • WW Other Consumer Services
  • PRLD Medicinal Chemicals and Botanical Products
  • Sector
  • WW Consumer Discretionary
  • PRLD Health Care
  • Exchange
  • WW Nasdaq
  • PRLD Nasdaq
  • Market Cap
  • WW 70.7M
  • PRLD 63.3M
  • IPO Year
  • WW 2001
  • PRLD 2020
  • Fundamental
  • Price
  • WW $0.88
  • PRLD $1.04
  • Analyst Decision
  • WW Buy
  • PRLD Buy
  • Analyst Count
  • WW 5
  • PRLD 3
  • Target Price
  • WW $3.44
  • PRLD $5.33
  • AVG Volume (30 Days)
  • WW 4.4M
  • PRLD 408.0K
  • Earning Date
  • WW 11-06-2024
  • PRLD 11-06-2024
  • Dividend Yield
  • WW N/A
  • PRLD N/A
  • EPS Growth
  • WW N/A
  • PRLD N/A
  • EPS
  • WW N/A
  • PRLD N/A
  • Revenue
  • WW $807,465,000.00
  • PRLD $3,000,000.00
  • Revenue This Year
  • WW N/A
  • PRLD N/A
  • Revenue Next Year
  • WW N/A
  • PRLD N/A
  • P/E Ratio
  • WW N/A
  • PRLD N/A
  • Revenue Growth
  • WW N/A
  • PRLD N/A
  • 52 Week Low
  • WW $0.67
  • PRLD $1.00
  • 52 Week High
  • WW $9.77
  • PRLD $6.80
  • Technical
  • Relative Strength Index (RSI)
  • WW 41.85
  • PRLD 21.69
  • Support Level
  • WW $0.81
  • PRLD $1.14
  • Resistance Level
  • WW $1.24
  • PRLD $1.36
  • Average True Range (ATR)
  • WW 0.12
  • PRLD 0.11
  • MACD
  • WW -0.03
  • PRLD 0.03
  • Stochastic Oscillator
  • WW 17.42
  • PRLD 7.53

About WW WW International Inc.

WW International Inc is a provider of weight loss solutions. The firm offers its members access to in person workshops and digital solutions as a part of its weight loss and weight management programs. Its digital app provides members access to tools such as, trackers for food, water, activity, weight, content regarding behavioral techniques for building healthy habits and other related tools. Along with its in person workshops and digital solutions, the company also provides members who medically qualify access to clinicians who can prescribe weight management medications when clinically appropriate. The company generates majority of its revenue in the form of Subscription Revenue. Geographically, the company generates key revenue from North America and rest from International markets.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.

Share on Social Networks: